Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis.
J Transl Med. 2023 Nov 22;21(1):839. doi: 10.1186/s12967-023-04706-2.
J Transl Med. 2023.
PMID: 37993937
Free PMC article.
IKK/NF-κB and ROS signal axes are involved in Tenacissoside H mediated inhibitory effects on LPS-induced inflammatory osteolysis.
Xie X, Chen W, Xu M, Chen J, Yang T, Wang C, Su Y, Zhao J, Xu J, Liu Q.
Xie X, et al.
Cell Prolif. 2024 Jan;57(1):e13535. doi: 10.1111/cpr.13535. Epub 2023 Aug 8.
Cell Prolif. 2024.
PMID: 37551727
Free PMC article.
Item in Clipboard
Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL-induced activation of NF-κB and MAPK signaling pathways and ROS.
Huang J, Song D, Xu M, Gan K, Wang C, Chen L, Huang Q, Chen J, Su Y, Xu J, Zhao J, Liu Q.
Huang J, et al.
Phytother Res. 2024 Aug 4. doi: 10.1002/ptr.8299. Online ahead of print.
Phytother Res. 2024.
PMID: 39098645
Item in Clipboard
Cite
Cite